The SAXS studies of complexation dicationic gemini surfactants with
Transkrypt
The SAXS studies of complexation dicationic gemini surfactants with
ISSRNS 2014: Abstractts / Synchrotronn Radiation in Natural N Sciencee Vol. 13, No. 1--2 (2014) P-04 P--05 The SAXS studies of coomplexation n dicationic gemini surffactants with low moleccular nucleicc acids DNA and siRNA SAX XS studies of o zwitterion nic lipoplexees – nanosystem n based on ph hospholipidss and d surfactants as innovattive delivery y systems for gene therap py W. Andrzejew wska*, M. Skkupin and M. Kozak K P. Egierska, E M. Skupin*, S B. Urrban*, J. Wolaak, W. Andrzejewska A a, Z. Pietralik and M. Kozak k Department off Macromolecullar Physics, Faaculty of Physiccs, A. Mickiewicz Unniversity, ul.Um multowska 85, 61-614 6 Poznań, Poland Departament of Moolecular Physiccs, Faculty of Ph hysics, Adam Mickkiewicz Universsity, 85b, Umulltowska, 61-614 4 Poznań, Pola and Keywords: geemini surfactantts, DNA, siRNA A, gene therapyy *email: andrzzejewskaw@gm mail.com Keywords: small anngle scattering of synchrotron radiation, genee theraapy, sulfobetainne derivatives Specificc physico-cheemical properrties of dicatiionic (gemini) surffactants are thhe reason for a broad theirr use in studies ass delivery sysstems of theraapeutic moleccules (i.e. nucleicc acids) intoo cells. To support the cell transfection process, the carrier c molecuules must connnect with a therappeutic molecuules and form stable compllexes [1,2]. Due to the self-aassembly proocess, in soluution complexes between b nucleic acids and gemini g surfactants are organized in differentt structural foorms, such ass for example: lam mellaes, micellls or hexagonal phase. Very prromising methhod to study of o such system ms is small angle scattering of synchrotron radiation r (SA AXS). This methodd is able to demonstrate d s structural chaanges occur within the studied deelivery system ms [3,4]. The preesented here experimental e r results concernn the structural analysis a (SR R-SAXS) of o mixtures of bis(1-dodecyyl imidazole) derivatives with w low moleccular DNA and RN NA. The preseence of characcteristic diffracction peaks (see Figure F 1) inddicates probaable formationn of cubic and hexxagonal phasees in the studied solutions. *[email protected] ;*[email protected] In I the recent years theree has been a number off tech hnological breeakthroughs tthat have allo owed clinicall trialls in gene therapy [1].. Progress in i molecularr med dicine, especiaally discoverinng new routess and methodss for gene deliverry has proviided promisin ng means off treatment of geneetic disorders and cancers. Developmentt of effective e genee carriers whicch can increaase specificityy of taargeting and decrease d harm mfulness to adjjacent healthyy tissu ues is very im mportant. Suiitable for thiss purpose aree thou ught to be delivery d nanoosystems bassed on lipid-surffactant mixturres [2]. The aim of this study was too deteermine the poossibility to uuse amphoteriic surfactantss (zwitterionic alkkyl derivativees of sulfobetaine [3]) ass com mplexing agennts for nucleic acids, with w potentiall appllications for gene g deliveryy [4]. A seriess of the smalll anglle scattering of synchrotrron radiation n (SR-SAXS)) meaasurements was w performed on selecteed lipoplexess baseed on short DNA D duplex (21 bp) and d zwitterionicc surffactants. The T poster prresents the sttructural anallysis of thesee DNA A/zwitterionicc surfactant systems on the basis off scatttering data.. The SAX XS data for f selectedd DNA A/zwitterionicc surfactant syystems were collected P122 beam m line of EM MBL Hamburgg Outstation on o PETRA IIII storrage ring at DESY. T The measureements weree perfformed on sollutions in 10 m mM sodium phosphate p pH H 7.5 with differentt DNA/surfacttant molar ratiio. Ack knowledgmentss: The study waas supported by research grant „GE ENERACJA PR RZYSZŁOŚCI” from Ministry of Science andd High her Education (Poland) – decission: 12/POIG/G GP/2013. Figure 1. Acknowledgm ments: The reseearch was suppported by reseearch grant (UMO--2011/01/B/ST55/00846) from National Science Centre (Poland). ____ _______________________________________ ___________ _______________________________________________________ [1] S. Mali, Indiaan J. Hum. Gennet. 19(1) (2013 3) 3-8. [2] N. L. Slackk, A. Ahmad, H. M. Evan ns, A. J. Lin,, C. E. Samuell, C.R. Safinya,, Curr. Med. Ch hem. 11 (2004)) 133. [3] M. Kozak, K. K Szpotkowskii, A. Kozak, R. R Zieliński, D.. Wieczorek, M. M J. Gajda, R Rad. Phys. Chem. 78 (2009)) S112. [4] N. Dan, Biophys. J. 73 (19977) 1842. [1] S. Szala (red.), Gene thherapy, PWN, 20003, Warszawa. [2] R. Zielińński, Surfactantts. sructure, prooperties, applicattions (WUP, 20009, Poznań) [3] Z. Pietraalik, R. Krzyszttoń, W. Kida, W. W Andrzejewskaa and M. Kozaak, Int. J. Mol. Sci. 14 (2013) 7642-7659. [4] Ch. Wanng, X. Li, D. Wettig, W I. Badea, M. Foldvarid, R. E. Verrall, Phys. Chem. Chem. C Phys. 9 (2007) 1616-11628. 69